title: Morbidity of intraoperative OKT3 administration in primary cadaveric renal transplant recipients.
authors.affiliation: Henry Ford Hospital, Detroit, Michigan 48202.
authors.forename: W
authors.initials: W
authors.lastname: Kupin
authors.forename: K K
authors.initials: KK
authors.lastname: Venkat
authors.forename: D
authors.initials: D
authors.lastname: Ikemiyashiro
authors.forename: H
authors.initials: H
authors.lastname: Ocdol
authors.forename: M
authors.initials: M
authors.lastname: Mozes
authors.forename: D
authors.initials: D
authors.lastname: Anaise
authors.forename: C
authors.initials: C
authors.lastname: Johnson
mesh_terms: D000328:Adult; D001794:Blood Pressure; D002102:Cadaver; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007432:Intraoperative Period; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D009017:Morbidity; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011674:Pulse
chemical_list: D016853:Muromonab-CD3